FDA released guidance on Circumstances that Constitute Delay [Regulatives / Guidelines]

posted by drgunasakaran1  – 2014-11-03 18:18 (4255 d 03:13 ago) – Posting: # 13827
Views: 4,071

Dear all,

FDA released Guidance for Industry, Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection.

http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM360484.pdf
—
Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
362 visitors (0 registered, 362 guests [including 22 identified bots]).
Forum time: 22:31 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5